| DOCU |
Anna Marrs |
N/A |
11/29/25 |
Award |
0 |
729 |
50,557 |
11,528 |
| DOCU |
Teresa Briggs |
N/A |
11/29/25 |
Award |
0 |
729 |
50,557 |
9,534 |
| DOCU |
Peter Solvik |
N/A |
11/29/25 |
Award |
0 |
729 |
50,557 |
214,784 |
| DOCU |
Blake J Irving |
N/A |
11/29/25 |
Award |
0 |
729 |
50,557 |
24,635 |
| DOCU |
Cain A Hayes |
N/A |
11/29/25 |
Award |
0 |
729 |
50,557 |
14,259 |
| DOCU |
Mary (Maggie) Agnes Wilderotter |
Chair |
11/29/25 |
Award |
0 |
729 |
50,557 |
59,074 |
| ARAY |
Ali Pervaiz |
PAO |
11/29/25 |
Award |
0 |
44,025 |
47,548 |
410,204 |
| OCS |
Arshad M Khanani |
N/A |
11/29/25 |
Award |
0 |
1,886 |
35,834 |
17,080 |
| PMTS |
Thomas M Furey |
N/A |
11/29/25 |
Award |
0 |
909 |
12,281 |
13,557 |
| PMTS |
Valerie Soranno Keating |
N/A |
11/29/25 |
Award |
0 |
909 |
12,281 |
32,354 |
| PMTS |
Ravi Mallela |
N/A |
11/29/25 |
Award |
0 |
909 |
12,281 |
7,058 |
| PMTS |
Lisa Oleson |
N/A |
11/29/25 |
Award |
0 |
909 |
12,281 |
4,380 |
| PMTS |
Nicholas Peters |
N/A |
11/29/25 |
Award |
0 |
909 |
12,281 |
43,557 |
| PMTS |
Sanford H Riley |
Chair |
11/29/25 |
Award |
0 |
909 |
12,281 |
52,366 |
| PMTS |
Abdul Marc Sheinbaum |
N/A |
11/29/25 |
Award |
0 |
909 |
12,281 |
17,436 |
| STRZ |
Dr Mark H Rachesky |
N/A |
11/29/25 |
Award |
0 |
1,358 |
10,658 |
22,134 |
| STRZ |
Emily Fine |
N/A |
11/29/25 |
Award |
0 |
1,358 |
10,658 |
14,188 |
| FANG |
American Shareholder |
N/A |
11/28/25 |
Sell |
152.59 |
2,000,000 |
305,180,000 |
99,686,727 |
| PSA-L |
American Shareholder |
N/A |
11/28/25 |
Buy |
16.3 |
3,558,182 |
58,000,139 |
23,338,608 |
| PSA-L |
American Shareholder |
N/A |
11/28/25 |
Sell |
16.3 |
3,067,398 |
50,000,119 |
9,818,776 |
| MEDP |
Dr August J Troendle |
Chair & CEO |
11/28/25 |
Sell |
603.28 |
56,482 |
34,074,472 |
5,408,747 |
| ACT |
American Shareholder |
N/A |
11/28/25 |
Sell |
37.36 |
878,006 |
32,804,148 |
116,132,456 |
| SE |
Rule 144 Affiliate |
N/A |
11/28/25 |
Sell |
136.38 |
238,000 |
32,458,440 |
N/A |
| PSA-Q |
American Shareholder |
N/A |
11/28/25 |
Buy |
18.83 |
743,351 |
13,999,984 |
13,872,659 |
| BNTX |
Ozlem Tureci |
Chf Med Off. |
11/28/25 |
Sell |
102.7 |
123,331 |
12,666,093 |
N/A |
| PSA-Q |
American Shareholder |
N/A |
11/28/25 |
Buy |
18.83 |
637,158 |
11,999,986 |
50,755,665 |
| PSA-Q |
American Shareholder |
N/A |
11/28/25 |
Buy |
18.83 |
530,965 |
9,999,989 |
44,244,762 |
| PI |
Daniel Patrick Gibson |
N/A |
11/28/25 |
Sell |
172.12 |
56,853 |
9,785,629 |
1,638,426 |
| UWMC |
Mat Ishbia |
Chair & CEO |
11/28/25 |
Sell |
5.74 |
1,629,785 |
9,361,322 |
3,333,832 |
| PSA-L |
American Shareholder |
N/A |
11/28/25 |
Buy |
16.3 |
429,436 |
7,000,017 |
15,230,859 |
| KEYS |
Ronald S Nersesian |
Chair |
11/28/25 |
Sell |
196.88 |
30,000 |
5,906,310 |
198,389 |
| KRMN |
Anthony Koblinski |
CEO |
11/28/25 |
Sell |
67.4 |
75,000 |
5,055,000 |
2,465,826 |
| PSA-Q |
American Shareholder |
N/A |
11/28/25 |
Buy |
18.83 |
212,386 |
3,999,995 |
20,718,569 |
| RDDT |
Steve Ladd Huffman |
CEO |
11/28/25 |
Award |
0 |
18,000 |
3,896,460 |
448,576 |
| CVNA |
Ryan S Keeton |
CBO |
11/28/25 |
Sell |
375.04 |
10,000 |
3,750,400 |
84,958 |
| CVNA |
Thomas Taira |
Div. Pres. |
11/28/25 |
Sell |
375.01 |
10,000 |
3,750,100 |
106,507 |
| VIAV |
Ilan Daskal |
CFO |
11/28/25 |
Award |
0 |
202,452 |
3,631,989 |
180,132 |
| URBN |
Richard A Hayne |
Chair & CEO |
11/28/25 |
Sell |
75.13 |
40,000 |
3,005,080 |
24,251,456 |
| WMT |
Doug Mcmillon |
CEO |
11/28/25 |
Sell |
109.57 |
19,416 |
2,127,329 |
5,394,440 |
| GLBE |
Nir Debbi |
Pres. |
11/28/25 |
Sell |
39.92 |
43,750 |
1,746,500 |
N/A |
| JLL |
Christian Ulbrich |
CEO |
11/28/25 |
Sell |
331.16 |
5,240 |
1,735,262 |
134,445 |
| CHYM |
Amine Asmerom |
CAO |
11/28/25 |
Sell |
20.16 |
84,589 |
1,704,977 |
222,170 |
| GROY |
Canadian Shareholder |
N/A |
11/28/25 |
Buy |
4.34 |
364,998 |
1,582,960 |
49,012,786 |
| PHAT |
Steven L Basta |
CEO |
11/28/25 |
Award |
0 |
90,000 |
1,405,800 |
83,250 |
| GILD |
Daniel O'day |
Chair & CEO |
11/28/25 |
Sell |
126.54 |
10,000 |
1,265,444 |
571,203 |
| VIR |
American Shareholder |
N/A |
11/28/25 |
Sell |
6.41 |
189,431 |
1,213,666 |
13,920,778 |
| TEAM |
Scott Farquhar |
N/A |
11/28/25 |
Sell |
150.12 |
7,665 |
1,150,699 |
168,630 |
| TEAM |
Michael Cannon-Brookes |
CEO |
11/28/25 |
Sell |
150.12 |
7,665 |
1,150,698 |
168,630 |
| PGR |
John P Sauerland |
CFO |
11/28/25 |
Sell |
228.48 |
5,000 |
1,142,400 |
236,612 |
| ADPT |
Kyle Piskel |
CFO |
11/28/25 |
Sell |
19.5 |
52,706 |
1,027,767 |
216,637 |
| ARAY |
Steven F. Mayer |
N/A |
11/28/25 |
Award |
0 |
895,391 |
967,022 |
1,295,620 |
| ARM |
Rene Haas |
CEO |
11/28/25 |
Sell |
134.49 |
6,152 |
827,400 |
N/A |
| CXT |
Aaron W Saak |
CEO |
11/28/25 |
Award |
0 |
13,915 |
783,415 |
32,870 |
| SYM |
Merline Saintil |
N/A |
11/28/25 |
Sell |
84.72 |
9,000 |
762,457 |
68,413 |
| ACGL |
Fran?ois Morin |
CFO & Treas |
11/28/25 |
Sell |
94.62 |
8,000 |
756,997 |
266,681 |
| CLFD |
Cheryl Podzimek Beranek |
CEO |
11/28/25 |
Award |
0 |
25,545 |
750,001 |
513,791 |
| STT |
Kathryn M Horgan |
Exe. VP & CHRO |
11/28/25 |
Sell |
118.55 |
5,676 |
672,890 |
104,978 |
| RPD |
Kevin Galligan |
N/A |
11/28/25 |
Buy |
15.71 |
41,545 |
652,672 |
6,760,149 |
| LOB |
James S Mahan iii |
Chair & CEO |
11/28/25 |
Sell |
32.11 |
20,000 |
642,158 |
6,554,875 |
| NPWR |
American Shareholder |
N/A |
11/28/25 |
Sell |
2.94 |
200,000 |
587,079 |
2,900,000 |
| GSAT |
Rebecca S Clary |
CFO |
11/28/25 |
Award |
0 |
9,524 |
578,584 |
107,898 |
| TPVG |
James P Labe |
Chair & CEO |
11/28/25 |
Buy |
6.4 |
79,868 |
511,131 |
1,335,707 |
| FSM |
Jorge A Ganoza Durant |
CEO |
11/28/25 |
Sell |
10.13 |
50,000 |
506,549 |
1,212,864 |
| CLFD |
John P Hill |
COO |
11/28/25 |
Award |
0 |
17,030 |
500,001 |
191,993 |
| ARWR |
Dr Mauro Ferrari |
N/A |
11/28/25 |
Sell |
56.39 |
8,750 |
493,413 |
68,764 |
| SPRU |
American Shareholder |
N/A |
11/28/25 |
Buy |
4.83 |
100,822 |
486,618 |
2,966,434 |
| LUCK |
Richard Meynard Born |
N/A |
11/28/25 |
Buy |
8.09 |
60,000 |
485,471 |
60,000 |
| PSA-Q |
American Shareholder |
N/A |
11/28/25 |
Sell |
25.72 |
18,003 |
463,098 |
270,268 |
| BFLY |
Jonathan M Rothberg |
N/A |
11/28/25 |
Sell |
3.08 |
132,570 |
408,183 |
7,348,545 |
| LSCC |
Pravin Desale |
R&D |
11/28/25 |
Sell |
69.93 |
5,708 |
399,147 |
105,913 |
| ABNB |
Nathan Blecharczyk |
Chf Strategy Ofc |
11/28/25 |
Sell |
116.71 |
3,307 |
385,960 |
187,313 |
| WRAP |
Woody Norris |
N/A |
11/28/25 |
Sell |
2.17 |
175,557 |
381,731 |
6,310,392 |
| COIN |
Frederick Ernest Ehrsam iii |
N/A |
11/28/25 |
Sell |
273.28 |
1,375 |
375,756 |
11,881 |
| GSHD |
Mark Miller |
CEO |
11/28/25 |
Buy |
72.34 |
5,000 |
361,700 |
35,000 |
| MKL |
Steven A Markel |
Chair |
11/28/25 |
Sell |
2100 |
170 |
356,999 |
78,759 |
| CLFD |
Daniel R Herzog |
CFO |
11/28/25 |
Award |
0 |
11,495 |
337,493 |
84,994 |
| CENTA |
Christopher T Metz |
N/A |
11/28/25 |
Sell |
30.91 |
10,000 |
309,059 |
11,721 |
| GXO |
Todd Christopher Cooper |
N/A |
11/28/25 |
Buy |
50.59 |
6,000 |
303,540 |
10,040 |
| AURX |
David Emerson Jorden |
CEO/CFO |
11/28/25 |
Sell |
1.5 |
200,000 |
300,000 |
1,946,755 |
| SBLK |
Charis Plakantonaki |
Chf Strategy Ofc |
11/28/25 |
Sell |
19.93 |
15,000 |
298,948 |
N/A |
| MANH |
Eric Andrew Clark |
CEO |
11/28/25 |
Sell |
176.4 |
1,600 |
282,236 |
50,486 |
| YCBD |
T Ronan Kennedy |
CEO/CFO |
11/28/25 |
Award |
0 |
445,000 |
275,011 |
513,722 |
| SBRA |
Richard K Matros |
Chair & CEO |
11/28/25 |
Award |
0 |
13,141 |
256,382 |
2,492,539 |
| INSP |
Shawn T Mccormick |
N/A |
11/28/25 |
Sell |
127.48 |
2,000 |
254,960 |
29,046 |
| NOW |
Paul Edward Chamberlain |
N/A |
11/28/25 |
Sell |
808 |
300 |
242,400 |
9,586 |
| ELAN |
Kirk P Mcdonald |
N/A |
11/28/25 |
Award |
0 |
10,314 |
240,007 |
88,714 |
| ELAN |
Dr Denise Scots-Knight |
N/A |
11/28/25 |
Award |
0 |
10,314 |
240,007 |
88,714 |
| ELAN |
Dr. Stacey Ma |
N/A |
11/28/25 |
Award |
0 |
10,314 |
240,007 |
12,853 |
| ELAN |
Kapila K Anand |
N/A |
11/28/25 |
Award |
0 |
10,314 |
240,007 |
94,973 |
| ELAN |
Art A Garcia |
N/A |
11/28/25 |
Award |
0 |
10,314 |
240,007 |
91,278 |
| ELAN |
Paul S Herendeen |
N/A |
11/28/25 |
Award |
0 |
10,314 |
240,007 |
84,813 |
| ELAN |
R David Hoover |
N/A |
11/28/25 |
Award |
0 |
10,314 |
240,007 |
332,693 |
| ELAN |
Dr Deborah Turner Kochevar |
N/A |
11/28/25 |
Award |
0 |
10,314 |
240,007 |
89,714 |
| ELAN |
Lawrence Erik Kurzius |
Chair |
11/28/25 |
Award |
0 |
10,314 |
240,007 |
121,773 |
| ELAN |
Michael J Harrington |
N/A |
11/28/25 |
Award |
0 |
10,314 |
240,007 |
109,577 |
| WBD |
Lori C Locke |
CAO |
11/28/25 |
Sell |
23.54 |
10,000 |
235,400 |
140,084 |
| NOW |
Lawrence Johnell Jackson |
N/A |
11/28/25 |
Sell |
810.22 |
265 |
214,709 |
323 |
| T |
John T Stankey |
Chair & CEO |
11/28/25 |
Award |
0 |
7,570 |
196,972 |
1,172,940 |
| DEFI.NE |
Mikael Tandetnik |
N/A |
11/28/25 |
Sell |
1.51 |
125,455 |
189,437 |
1,000,000 |
| HSCS |
Andrew Simpson |
Chair & CEO |
11/28/25 |
Award |
0 |
70,000 |
187,600 |
74,382 |